Loss of <i>BAP1</i> expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development
Carlos R. Figueiredo(University of Turku), Sarah E. Coupland(University of Liverpool)
Cited by 157
Related Papers
ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016
|ESMO Open|2016|129
A novel microtubule de-stabilizing complementarity-determining region C36L1 peptide displays antitumor activity against melanoma in vitro and in vivo
|Scientific Reports|2015|23
TIMP-1 is an activator of MHC-I expression in myeloid dendritic cells with implications for tumor immunogenicity
|Genes and Immunity|2024|16
Novel prognostication biomarker adipophilin reveals a metabolic shift in uveal melanoma and new therapeutic opportunities
|The Journal of Pathology|2023|10